BSEInsider Trading / SAST6d ago · 14 Aug 2026, 02:42 pm

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd

Dr. Agarwals Health Care Ltd · 544350

✦ AI SummaryPledge

Claymore Investments (Mauritius) Pte. Ltd. has disclosed a sale of 1,59,00,000 shares of Dr. Agarwals Health Care Ltd, reducing their stake from 20.06% to 15.04%.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

1B52728B_2C36_45CC_9D5B_332178D5CF42_144245.pdf

pdf

Download →
View document text
Claymore Investments (Mauritius) Pte. Ltd. Registration No. 076038 (C1/GBL) August 13, 2026 Dr.Agarwals Health Care Limited 6th Floor, Menon Eternity, 1st Main Road, Austin Nagar, Alwarpet, Chennai, Tamil Nadu, 600018 BSE Limited Listing Department 1stFloor, New Trading Ring Rotunda Building P.J. Tower Dalal Street, Fort Mumbai 400 001 National Stock Exchange of IndiaLimited Listing Department Exchange Plaza, 5thFloor Plot No. C/1, G-Block Bandra Kurla Complex Bandra(East) Mumbai 400 051 Dear Sir, Sub: Disclosure under Regulation 29(2)of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Please find attached the disclosure under Regulation 29 (2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 with respect to the sale of shares of Dr.Agarwals Health Care Limitedby Claymore Investments (Mauritius) Pte. Ltd. Yours faithfully, For and on behalf of Claymore Investments (Mauritius) Pte. Ltd. Authorised signatory Name: Designation: Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part A - Details of the Sale Name of the Target Company Dr. Agarwal’s Health Care Limited (TC) Name(s) of the seller and Persons Seller - Claymore Investments (Mauritius) Pte. Ltd. Acting in Concert (PAC) with the seller PAC– Arvon Investments Pte. Ltd. Whether the seller belongs to No Promoter/Promoter group Name(s) of the Stock Exchange(s) BSE Limited and National Stock Exchange of India Limited where the shares of TC are Listed Details of the sale are as follows Number % w.r.t. total % w.r.t. total share/voting diluted capital wherever share/voting applicable (*) capital of the TC (**) Before the sale under consideration, holding of: a) Shares carrying voting Seller - 3,22,96,300 Seller – 10.19% Seller- 10.12% rights PAC - 3,12,75,470 PAC – 9.87% PAC– 9.80% b) Shares in the nature of encumbrance (pledge/ lien/ Nil Nil Nil non-disposal undertaking/ others) c) Voting rights (VR) Nil Nil Nil otherwise than by shares d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 6,35,71,770 20.06% 19.91% Details of acquisition / sale a) Shares carrying voting rights Seller – 1,59,00,000 Seller – 5.02% Seller-4.98% acquired/sold PAC - NIL PAC - NIL PAC - NIL b) VRs acquired/sold otherwise Nil Nil Nil than by shares c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold Nil Nil Nil d) Shares encumbered/invoked/releas ed by the acquirer 1,59,00,000 5.02% 4.98% e) Total (a+b+c+/-d) After the acquisition/sale holding of: a) Shares carrying voting rights Seller – 1,63,96,300 Seller – 5.17% Seller-5.14% PAC - 3,12,75,470 PAC – 9.87% PAC – 9.80% b) Shares encumbered with the Nil Nil Nil acquirer c) VRs otherwise than by shares Nil Nil Nil d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d) 4,76,71,770 15.04% 14.93% Mode of acquisition / sale (e.g. Sale on the open market open market / off-market/ public issue / rights issue / preferential allotment / inter-se transfer etc.) Date of acquisition/sale of The 2% limit was crossed on August 12, 2026. shares/VR or date of receipt of intimation of allotment of shares whichever is applicable. Equity share capital / total voting INR 31,69,83,028 comprising 31,69,83,028 equity shares of face capital of the TC before the said value of INR 1/- each. acquisition/sale(*) Equity share capital/ total voting INR 31,69,83,028 comprising 31,69,83,028 equity shares of face capital of the TC after the said value of INR 1/- each. acquisition/sale(*) Total diluted share/voting capital INR 31,92,62,876 comprising 31,92,62,876 equity shares of face of the TC after the said sale (**) value of INR 1/- each. Note: (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement i.e. as on June 30, 2026. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC as on June 30, 2026. (#) All percentage shareholding in this disclosure has been rounded-up to two decimal places for the ease of reference. Signatureoftheacquirer/seller / Authorised Signatory For Claymore Investments (Mauritius) Pte. Ltd. Name: Designation: AuthorisedSignatory Place: Date: